[1]李迈,米登海,杨丽霞,等.中医药基于JAK/STAT信号通路治疗糖尿病肾病研究概述[J].西部中医药,2023,36(09):157-161.[doi:10.12174/j.issn.2096-9600.2023.09.35]
　LI Mai,MI Denghai,YANG Lixia,et al.Overview of TCM in the Treatment of Diabetic Nephropathy Based on JAK/STAT Signaling Pathway[J].Western Journal of Traditional Chinese Medicine,2023,36(09):157-161.[doi:10.12174/j.issn.2096-9600.2023.09.35]
点击复制

中医药基于JAK/STAT信号通路治疗糖尿病肾病研究概述
分享到：

《西部中医药》[ISSN:2096-9600/CN:62-1204/R]

卷:
36
期数:
2023年09期
页码:
157-161
栏目:
出版日期:
2023-09-15

文章信息/Info

Title:
Overview of TCM in the Treatment of Diabetic Nephropathy Based on JAK/STAT Signaling Pathway
作者:
李迈1, 米登海2, 杨丽霞2, 李次艳1
1.甘肃中医药大学，甘肃 兰州 730000
2.甘肃省中医药研究院，甘肃 兰州 730050
Author(s):
LI Mai1, MI Denghai2, YANG Lixia2, LI Ciyan1
1.Gansu University of TCM, Lanzhou 730000, China
2.Gansu Province Academy of TCM, Lanzhou 730050, China
关键词:
糖尿病肾病; JAK/STAT信号通路; 中医药; 综述
Keywords:
diabetic nephropathy; JAK/STAT signaling pathway; TCM; review
分类号:
R256.5
DOI:
10.12174/j.issn.2096-9600.2023.09.35
文献标志码:
A
摘要:
就酪氨酸蛋白激酶/信号转导因子和转录活化因子（janus kinase/signal transducer and activator of transcription，JAK/STAT）信号通路对糖尿病肾病（diabetic nephropathy，DN）的作用机制，以及针对此通路的中医药相关研究进行综述，指出DN是糖尿病（diabetes mellitus，DM）最严重的慢性并发症之一，也是威胁现代人类健康的重要疾病之一，对患者的日常生活造成了诸多不利影响，但DN确切的发生发展机制尚未明确，近年来JAK/STAT信号通路对DN的调控作用已成为研究热点。
Abstract:
The paper sums up the mechanism of JAK/STAT signaling pathway in diabetic nephropathy (DN) and TCM related studies on this pathway, it is pointed out that DN is one of the most serious chronic complications of diabetes, and also one of the important diseases threatening modern human health, which has caused many adverse effects on patients' daily life, but the exact mechanism of the occurrence and development of DN has not been clearly elaborated, the regulatory role of JAK/STAT signaling pathway in DN has been the hot topic in recent years.

相似文献/References:

[1]林晓芬,黄燕璇.益肾汤联合厄贝沙坦及胰激肽原酶治疗早期糖尿病肾病的疗效观察[J].西部中医药,2013,26(07):68.
　LIN Xiaofen,HUANG Yanxuan.Clinical Observation on YiShenTang Combined with Irbesartan and Pancreatic Kininogenase in the Treatment for Early Diabetic Nephropathy[J].Western Journal of Traditional Chinese Medicine,2013,26(09):68.
[2]王学琦,李丰华,张荣华,等.温肾汤治疗早期糖尿病肾病80例[J].西部中医药,2013,26(09):62.
　WANG Xueqi,LI Fenghua,ZHANG Ronghua,et al.WenShenTang for 80 Cases of Early Diabetic Nephropathy[J].Western Journal of Traditional Chinese Medicine,2013,26(09):62.
[3]任芳,徐厚谦△.黄芪注射液治疗糖尿病肾病有效性及安全性的系统评价[J].西部中医药,2014,27(01):77.
　REN Fang,XU Houqian.Systematic Review of the Effectiveness and Safety of HuangQi Injection in Treating Diabetic Nephropathy[J].Western Journal of Traditional Chinese Medicine,2014,27(09):77.
[4]丁夏楠,许筠△,苏建平,等.益肾逐瘀方治疗糖尿病肾病蛋白尿37例[J].西部中医药,2014,27(04):96.
　DING Xianan,XU Jun,SU Jianping,et al.Treatment for Proteinuria of 37 Patients with Diabetic Nephropathy by Kidney-invigorating Stagnation-dispelling Prescription[J].Western Journal of Traditional Chinese Medicine,2014,27(09):96.
[5]肖远莉.循证护理的优效性及影响因素分析———来自终末期糖尿病肾病患者血液透析的证据[J].西部中医药,2014,27(08):127.
[6]刘涛.缬沙坦联合复方丹参滴丸对早期2型糖尿病肾病患者尿微量白蛋白的影响[J].西部中医药,2015,28(05):106.
[7]连琯,史晓伟.当归补血汤合金水宝治疗早期糖尿病肾病16例临床观察[J].西部中医药,2013,26(06):68.
　LIAN Guan,SHI Xiaowei.Clinical Observation on DangGui BuXueTang and JinShuiBao in Treating 16 Cases of Early Diabetic Nephropathy[J].Western Journal of Traditional Chinese Medicine,2013,26(09):68.
[8]任芳,徐厚谦△.黄芪注射液治疗糖尿病肾病随机对照试验报告质量评价[J].西部中医药,2013,26(12):1.
　REN Fang,XU Houqian.Quality Evaluation of the Report for Randomized Controlled Trials of HuangQi Injection in Treating Diabetic Nephropathy[J].Western Journal of Traditional Chinese Medicine,2013,26(09):1.
[9]朱苗蕊,指导：金智生.糖脂平治疗早期糖尿病肾病60例疗效观察*[J].西部中医药,2013,26(03):74.
　ZHU Miaorui,Director: JIN Zhisheng.Clinical Observation on TangZhiPing in Treating 60 Cases of Early Diabetic Nephropathy[J].Western Journal of Traditional Chinese Medicine,2013,26(09):74.
[10]马天寿.血塞通联合西药治疗糖尿病肾病80例[J].西部中医药,2013,26(08):96.
　MA Tianshou.XueSaiTong Injection and Western Medicine in Treating 80 Cases of Diabetic Nephropathy[J].Western Journal of Traditional Chinese Medicine,2013,26(09):96.

备注/Memo

备注/Memo:
李迈（1994—），男，硕士学位。研究方向：糖尿病的中医药防治。省属科研院所创新能力建设专项（20JR10RA432）。
更新日期/Last Update: 2023-09-15